The tumor suppressor function of SMAD2 [18,22,75,76] and the pro-tumorigenic role of SMAD3 [16,17,22,77] have already been demonstrated in various models, but only a few studies have been conducted to assess the selective importance of SMAD2 vs. SMAD3 in cancer progression. The gene discussed is SMAD3; the disease is neoplasm.